June 2020: Myasthenia Gravis Awareness Month

Myasthenia Gravis is an autoimmune neuromuscular disorder  characterized by double vision, drooping eyelids, trouble talking and skeletal muscle weakness. It affects women more frequently than men. The symptoms usually peak in women during their 20s and 30s, in men – during their 50s and 60s.

Presently there is no cure for Myasthenia Gravis. However, the available treatments let most patients manage the symptoms effectively, lead normal lives and have a normal life expectancy.

Myasothenia Gravis Awareness month is organized by Myasthenia Gravis Foundation of America, Inc. and observed annually. Due to the increase of awareness, many more patients have been diagnosed with the disease and were able to receive treatment in the recent years.

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2020 Global Clinical Trials, LLC

All rights reserved.